It is not even fathomable to me that a CEO, with the integrity of Missling, would repeatedly state that all endpoints were met, if they weren't. With all the other data showing efficacy and endpoints met, leads me to believe 100% what the CEO has repeatedly stated.
He obviously believes (with likely feedback) that A2-73 will be approved relatively soon; otherwise, he wouldn't be talking commercialization.